See also this year's filing and all EDGAR filings for this company.
PDF Report 0000827871_2019_Eagle_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000827871, Eagle Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 163,844,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 57,846,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,397,000 |
| 3 | remainder_Assets | 14,516,000 |
| 4 | LiabilitiesCurrent | 39,686,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 27,808,273 |
| 8 | SellingGeneralAndAdministrativeExpense | 46,240,164 |
| 9 | ResearchAndDevelopmentExpense | 46,145,581 |
| 10 | remainder_Expenses | 43,861,856 |
| 11 | remainder_Revenues | 181,992,824 |
| 12 | remainder_NetIncome | -10,227,244 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 238,603,000 |
| 1 | Liabilities | 39,686,000 |
| 2 | Expenses | 164,055,874 |
| 3 | Revenues | 181,992,824 |
| 4 | StockholdersEquity | 198,917,000 |
| 5 | NetIncome | 7,709,706 |
| 6 | ComprehensiveNetIncome | 7,709,706 |
| 7 | BaseVar | 317,282,471 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.17 |
| 9 | EconomicCapitalRatio | 3.80 |
Edgar->Model Mapping
Feature Distribution
Change over Time
